These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26587904)

  • 21. Interaction between warfarin and cranberry juice.
    Paeng CH; Sprague M; Jackevicius CA
    Clin Ther; 2007 Aug; 29(8):1730-5. PubMed ID: 17919554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inadvertent exaggerated anticoagulation following use of bismuth subsalicylate in an enterally fed patient receiving warfarin therapy.
    Bingham AL; Brown RO; Dickerson RN
    Nutr Clin Pract; 2013 Dec; 28(6):766-9. PubMed ID: 24163322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of casopitant, a novel NK-1 receptor antagonist, on the pharmacokinetics and pharmacodynamics of steady-state warfarin.
    Kirby LC; Johnson BM; Adams LM; Eberwein DJ; Zhang K; Murray SC; Lates CD; Blum RA; Morris SR
    J Clin Pharmacol; 2010 May; 50(5):566-75. PubMed ID: 20220045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of soy milk on warfarin efficacy.
    Cambria-Kiely JA
    Ann Pharmacother; 2002 Dec; 36(12):1893-6. PubMed ID: 12452752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of capecitabine and S-1 on anticoagulant activity of warfarin in patients with gastrointestinal cancer.
    Hata T; Kudo T; Sakai D; Takahashi H; Haraguchi N; Nishimura J; Hata T; Mizushima T; Yamamoto H; Doki Y; Mori M; Satoh T
    Cancer Chemother Pharmacol; 2016 Aug; 78(2):389-96. PubMed ID: 27339150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Warfarin and celecoxib interaction.
    Mersfelder TL; Stewart LR
    Ann Pharmacother; 2000 Mar; 34(3):325-7. PubMed ID: 10917378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Probable interaction between warfarin and antitumor agents used in R-ESHAP chemotherapy.
    Suzuki T; Koga H; Yamazaki S; Saeki H; Tanaka H; Nishimura M; Nakaseko C; Nakasa H; Nakamura H; Ariyoshi N; Kitada M
    Clin Ther; 2008 Jun; 30(6):1155-9. PubMed ID: 18640471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the 5-fluorouracil-warfarin and capecitabine-warfarin drug interactions.
    Shah SR; Martin R; Dowell JE; Ussery SM
    Pharmacotherapy; 2010 Dec; 30(12):1259-65. PubMed ID: 21128758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of acetaminophen on international normalized ratio in patients receiving warfarin therapy.
    Hughes GJ; Patel PN; Saxena N
    Pharmacotherapy; 2011 Jun; 31(6):591-7. PubMed ID: 21923443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of acetaminophen on the international normalized ratio in patients stabilized on warfarin therapy.
    Parra D; Beckey NP; Stevens GR
    Pharmacotherapy; 2007 May; 27(5):675-83. PubMed ID: 17461702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A probable interaction between warfarin and the antiretroviral TRIO study regimen.
    Liedtke MD; Vanguri A; Rathbun RC
    Ann Pharmacother; 2012 Nov; 46(11):e34. PubMed ID: 23115227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Critically elevated INR in a patient on warfarin after increase in extended-release niacin dose.
    Christopher A
    Ann Pharmacother; 2011 Nov; 45(11):e58. PubMed ID: 22010004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increasing warfarin dosage reductions associated with concurrent warfarin and repeated cycles of 5-Fluorouracil therapy.
    Davis DA; Fugate SE
    Pharmacotherapy; 2005 Mar; 25(3):442-7. PubMed ID: 15843293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A retrospective study of coagulation abnormalities in patients receiving concomitant capecitabine and warfarin.
    Shah HR; Ledbetter L; Diasio R; Saif MW
    Clin Colorectal Cancer; 2006 Jan; 5(5):354-8. PubMed ID: 16512995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Probable Interaction Between Warfarin and Inhaled and Oral Administration of Cannabis.
    Hsu A; Painter NA
    J Pharm Pract; 2020 Dec; 33(6):915-918. PubMed ID: 31319733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction between gemfibrozil and warfarin: case report and review of the literature.
    Dixon DL; Williams VG
    Pharmacotherapy; 2009 Jun; 29(6):744-8. PubMed ID: 19476425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated International Normalized Ratio values in a patient receiving warfarin and ceftaroline.
    Farhat NM; Hutchinson LS; Peters M
    Am J Health Syst Pharm; 2016 Jan; 73(2):56-9. PubMed ID: 26721534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hereditary warfarin resistance].
    Lappegård KT
    Tidsskr Nor Laegeforen; 2000 Nov; 120(27):3257-8. PubMed ID: 11187165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experience with ifosfamide and etoposide combination chemotherapy in extensive-disease small-cell lung cancer.
    Wu MF; Perng RP; Chen YM; Liu JM; Yang SL; Whang-Peng J
    Zhonghua Yi Xue Za Zhi (Taipei); 1997 Aug; 60(2):67-73. PubMed ID: 9360330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.